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Abstract
Background: The aim of this study was designed to investigate the care-effectiveness of different
healthcare models for schizophrenic patients and the impact of it on caregivers.
Methods: Sample cases were randomly selected from southern Taiwan, 257 patients in redesigned
care network, including a general hospital, a chronic ward, 10 outpatient clinics, and
multialternative community programs, was compared to 247 patients in other traditional
healthcare provider that were utilized as the control group. The quality of life (QOL) questionnaire
and the Chinese health questionnaire (CHQ) were used.
Results: The controls had longer duration of illness (p = 0.001) and were older (p = 0.004). The
average resource utilization in the study group (US$ 2737/year, per case) was higher than the
control group (US$ 2041) (t = 7.91, p < 0.001). For the study group, the average length of stay was
shorter, but the admission rate was higher. The QOL of the patients in the study group was better
than that of the controls (p = 0.01). The family burden of the study group was lower (p = 0.035)
and the score of general health questionnaire higher (p = 0.019).
Conclusion: We found that patients in the redesigned care network had a better QOL, lower
family burden, decreased days of hospital stay, higher medical resource utilization and less frequent
admission to a hospital, and the caregivers had better mental health. Although the costs were
higher, the continued care network was more helpful in providing comprehensive mental illness
services.
Background
The impact of deinstitutionalization and the development
of community treatment programs for people with serious
and chronic mental illness have been frequently discussed
for the last 40 years [1,2]. The issue regarding the cost-
effectiveness for schizophrenics and caregivers has been
given significantly more attention [3-10]. Hence, the costs
associated with schizophrenia have become an important
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issue for Taiwan's Bureau of National Health Insurance
(BNHI) [11]. The Kao-Ping Branch of the BNHI in Taiwan
calculated the annual medical cost of schizophrenia in
2001 as 4.16% of the total medical budget (US$
22,928,522/US$ 551,051,725). Therefore, apart from
analyzing the utilization of medical resources among pro-
viders, the BNHI has also focused on an evaluation and
comparison of medical outcomes.
Mental health services in Taiwan are determined partly by
the BNHI, which makes overall plans for the national
health insurance program, which is a social insurance
structure. BNHI utilizes a fee-for-service reimbursement
policy. Publicly and privately owned providers of mental
healthcare services include general clinics, psychiatric
wards of general hospitals, specialized psychiatric hospi-
tals, chronic psychiatric hospitals, psychiatric rehabilita-
tion institutions, day hospital admissions, and home visit
services. Treatment plans among different organizations
are similar but inconsistent, and lack a complete health
network. There were a few patient referrals between organ-
izations. Consequently, patients presented with minor
problems at acute care hospitals, thus overcrowding hos-
pitals and compromising the quality of care. Although a
registration fee and a co-payment system apply to consul-
tations in general hospitals, medication costs and exami-
nation co-payments continue to rise. However,
schizophrenia is considered a severe disability under the
BNHI guidelines, and patients are entitled to a severe dis-
ability card, which allows them to access medical services
free of charge at any institution. This system not only
increases accessibility to medical services for patients and
their families, but also increases the utilization of medical
resources. The BNHI has expressed concern over this situ-
ation, and has encouraged the establishment of a health
network among health service organizations, to provide
care to patients in a most cost-effective way.
This study was designed to compare the cost-effectiveness
of an integrated treatment model consisting of a teaching
hospital, psychiatric rehabilitation institutions, a day hos-
pital, community rehabilitation centers, daycare farms,
home-based care, and outpatient clinics, with those of the
traditional treatment model provided by psychiatric hos-
pitals or general acute care hospitals under the jurisdiction
of the Kao-Ping Branch of the BNHI. We determined the
differences in psychiatric resource utilization between
these two treatment models with distinct management
goals. The treatment outcomes of the two service provid-
ers were also explored in this study.
Methods
Participants
The patients of this study were recruited from Southern
Taiwan, consisted of 371 persons who randomly selected
by Alphabetic order from 1210 schizophrenic patients
from the redesigned care network model. The control
group consisted of 730 persons randomly selected by
Alphabetic order from 18,911 schizophrenic patients who
did not fall under the above-mentioned network of treat-
ment organizations.
A network system of mental health care in the Kao-Ping area
A network of mental health services was created by coor-
dinating a general acute care hospital, a day hospital, a
psychiatric rehabilitation institution, a community reha-
bilitation center, home visit providers, a specialized psy-
chiatric hospital, and 10 local clinics. To provide
continued care, 1,210 severely schizophrenic patients, or
1/13 of the schizophrenic patients in Kao-Ping county,
were assessed and placed in a different mental care facility,
based on the clinical pathway of the treatment model
operating at the particular health service organization.
Patients were referred to appropriate organizations and
with flexibility in timing, place, provider, service, and cost
principles.
Research materials
The Taiwanese concise version of the quality of life questionnaire of 
the world health organization (WHO-QOL-BREF)
The World Health Organization Quality of Life [12-14]
(WHOQOL) is a 100-item generic measure designed for
use with individual quality of life and mental health. The
Taiwan version of WHOQOL was modified and simpli-
fied by Yao [15]. Apart from simplifying and translating
the questionnaire into Chinese, culturally relevant addi-
tional questions of respect and food aspect were included
to form a self-completing questionnaire consisting of 28
questions with a 5-point scale. The questionnaire evalu-
ates the objective quality of life of the participants over the
past 2 weeks regarding four main aspects: physiological
health, psychological health, social relations, and envi-
ronmental dimension. Higher scores correspond to a bet-
ter quality of life. Cronbach's Alpha was 0.68 to 0.77 and
test-retest reliability was 0.41 to 0.79 [15].
Caregiver's burden questionnaire
This questionnaire consisted of 18 questions to assess the
burden of the caregivers. The questionnaire looked at
problems and emotions encountered by caregivers during
the care of a schizophrenic patient, and included two
major categories of objective and subjective burdens. Five
subcategories were also examined: There were seven ques-
tions on "family interference," a subjective burden; the
objective burden included two questions on "stigma-
tism," two questions on "guilt," three questions on the
"anxiety state of the caregiver," and two questions on
"patient dependency." The responses are in 5-point Likert-
type scale. Each item was scored from 0 (never) to 5
(almost always), and the scores were added up in total toBMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
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reflect the burden on the caregiver. Higher scores repre-
sent heavier burdens [16,17]. Overall, the internal consist-
ency for the questionnaire was 0.88, and for each
individual item, 0.65–0.90. The reliability of the ques-
tionnaire was 0.90, and the correlation coefficient
between each individual item and its subcategory was
0.45 [16,17].
Chinese health questionnaire (CHQ)
Cheng and Williams developed the CHQ in 1986 [18],
with reference to the General Health Questionnaire
designed by Goldberg and supplemented by some cultur-
ally relevant questions. There are 12 questions with a
weighted classification, sensitivity, and specificity of 89%,
70%, and 95%, respectively [19]. This questionnaire is a
self-assessed screening instrument used to assess psychiat-
ric morbidity, with a 4-point scale system with options of
"not a bit," "as usual," "slightly more than usual," and
"much more than usual." The CHQ can be applied effec-
tively in clinical and community settings. Its factor struc-
ture consistency is high and Cronbach's α coefficient for
internal consistency is between 0.83 and 0.92 [20]. This
questionnaire is suitable as a screening assessment for the
caregiver's state of psychological well-being.
Data collection
This study was approved by the hospital ethics committee,
which serves as the institutional review board. Starting in
September 2002, consent forms and a detailed study
description were sent to randomly selected patients and
their families by the Kao-Ping Branch of the BNHI. Post-
age-paid return envelopes were enclosed for the conven-
ience of the patients and for data collection. After
obtaining consent from patients and their main caregiver
to participate in the study, questionnaires were sent to the
patients and their families. The questionnaire recorded
variables including age, sex, duration of the disease, and
quality of life of the patient, and sex, age, marital status,
annual income, CHQ score, and burden score of the main
caregiver. If for any reason the questionnaires were not
completed, a senior and trained interviewer from the
Department of Health or this study team would pay a
home visit to help subjects complete the questionnaire.
Participants were asked to fill up the same questionnaires
6 months later, as well.
Statistical analysis
This study used SPSS statistical software version 10.1 [21]
to perform descriptive statistics and exploratory data anal-
yses, to determine whether independent variables were
normally distributed. A t test was used to compare the
results of the patient's quality of life, burden on the family
and caregivers, and CHQ scores.
Results
Baseline demographics
In the first phase of study, there were 257 out of 371
patients turned in their signed consent form. Seventy-six
patients refused to participate in the study. Thirty-two
patients had an incorrect mailing address. Four patients
had passed away, one was in police custody, and one had
an amended diagnosis. The control group consisted of
730 people randomly selected by a computer at the BNHI.
After two reminder mailings, 241 valid questionnaires
returned, 476 patients refused to participate in the study,
11 patients had passed away, one was in police custody,
and one had an amended diagnosis.
In the second phase, questionnaires were sent only to
those who returned a valid questionnaire in the first
phase. The study group returned 190 copies of valid ques-
tionnaires, 51 patients refused to participate, and 16 with
incorrect mailing addresses. The control group returned
133 copies of valid questionnaires, 86 patients refused
participation, 21 had an incorrect mailing address, and
one patient had died. Within the sampling population,
males predominated among those who refused to partici-
pate in both groups, in both the first and second phases of
the study.
With regard to demographic data, seven variables were
examined: the patient's sex, age, duration of the illness,
and the caregiver's sex, age, marital status, and annual
income. There were no significant differences in the
demographic data except that the patients in the control
group had a higher average age (p = 0.001) and longer
duration of the disease (p = 0.004) (Table 1).
Resource utilization
An analysis of the psychiatric resource utilization for
20,121 schizophrenic patients in this area showed an
average cost of US$ 2083 per patient per year in the Kao-
Ping area (data not shown). Frequencies of visits for the
two groups are shown in Table 2. As shown in Table 3,
clinical consultation costs were higher in the control
group than in the study group (p < 0.001). In terms of
home nursing care, almost every patient in the study
group had had home visits by healthcare staff, at an aver-
age of 2.9 times per year, which was significantly more
than the control group (p < 0.001); these home visits were
associated with higher costs in the study group than in the
control group (p  < 0.001). Regarding the length and
number of acute hospital admissions, both were higher in
the study group than in the control group (p < 0.001). The
average costs per admission were similar between the two
groups (p = 0.08). The study group had a significantly
shorter length of chronic hospital admission (160 days)
than the control group (210 days; p < 0.001); the average
cost per admission was higher in the control group (p <BMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
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0.001), and the number of admissions was higher in the
study group (p  < 0.001). The average number of days
recorded for day admission was similar in both groups (p
= 0.192), but cost per admission was higher in the study
group than in the control group (p < 0.001). In terms of
the psychiatric rehabilitation institutions, average cost per
admission and number of admissions were both higher in
the control group than in the study group (p < 0.001).
Total medical expenses per admission at the above-men-
tioned organizations were US$ 2319 for the study group
and US$ 1467 for the control group (p < 0.001). Average
total medical costs per year were US$ 2737 for the study
group and US$ 2041 for the control group. Drug costs
accounted for 14.6% of the total costs in the study group
and 25.9% in the control group. Drug costs for the Kao-
Ping area accounted for 25% of the total medical expenses
(Table 3).
The results showed improvements in the patients' physio-
logical and psychological health, social relations, environ-
ment, and quality of life in the study group. However,
higher CHQ scores also meant a decline in the health of
the caregivers in the study group (p < 0.001). The decrease
in the caregiver's burden was statistically significant in the
study group (p < 0.001). The results are shown in Table 4.
Conversely, physiological (p = 0.007) and social relations
(p = 0.043) have statistically significant decrease in the
control group. Although the caregiver's burden was not
statistically significant in the controls (p = 0.882), higher
CHQ scores were shown in the 2nd test for the controls (p
< 0.001). The results are shown in Table 5.
Comparing outcome variables between the two groups,
the results showed that patients in the study group had
better physical health outcomes than the control group in
the 1st test (p = 0.02) and the 2nd test (p = 0.01). The psy-
chological health of the study group was better than that
of the control group in the 2nd test (p = 0.01). The envi-
ronmental health of the study group was better than that
of the control group in the 2nd test (p = 0.01); and the
total QOL score of the study group was higher than that of
the control group in the 2nd test (p = 0.01). The burden
on caregivers in the study group in the 2nd test was lower
than that in the control group (p = 0.035). For the CHQ
scores of caregivers, the 2nd test of the study group was
better than that of the control group (Table 6).
Discussion
The community-based network system of the current
study provides a full service to help psychiatric patients
Table 1: Demographic data of the two groups of schizophrenic patients and their caregivers
Patient Study group (n = 257) Controls (n = 241) χ2 p
Sex Male 171 146 3.07 0.080
Female 79 94
Data missing 7 7
Study group Controls t-test p
Age (years) 39.2 42.8 -3.45 0.001
Duration of disease (years) 13.6 16.1 -2.86 0.004
Hospital admission rate (%) 1.18 10.08
Caregiver Study group (n = 257) Controls (n = 247) t-test p
Age (years) 56.9 57.5 -0.51 0.61
Study group Controls χ2 p
Sex Male 122 120 0.28 0.597
Female 132 118
Data missing 3 9
Marital status Married 197 171 6.13 .152
Single 24 24
Others 36 52
Annual income <US$ 7500 153 130 7.16 0.061
US$ 7500–15,000 67 58
US$ 15,000–22,500 18 27
>US$ 22,500 11 20
US$ 1 = NT$ 32BMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
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develop skills for coping with the problem of living in the
community and which virtually decreases hospitalization.
Different to traditional hospital basis, community-based
multidisciplinary teams are not only responsible for indi-
vidual caseloads (case management) by homecare mem-
ber, but also provide linking and coordinating services by
a network system, that with a variety of community
resources. This model shows how patients who would be
treated in mental hospital can be successfully treated in
the community without shifting the burden of care to
their families. Despite the increasing costs of medication
reimbursement, and the increased use of the community
mobile team and outpatient clinic, the overall costs for the
mental health system were substantially reduced.
The direct costs of care were found to be much lower than
the costs in European countries. Average costs in Taiwan
were US$ 2084 (US$ 2737 for the study group and US$
2041 for the control group individually). Other countries
reported the following associated costs: US$ 2693 in
Spain [22], US$ 15,859 in Mannheim, Germany [23],
US$ 32,003 in West Lambeth, England (which includes
informal care costs) [24], US$ 5678 in Italy [25], and US$
7656 in South Verona, Italy [26]. When compared with
USA, there is 1.56 times as much cost as that in Taiwan,
with adjusted per capita income of the two countries. It
shows that the average costs in Taiwan are further less
than the costs in USA. In our study, the inpatient costs for
the study group were 78% (acute 55.2%, chronic 22.2%)
of the total health costs, and 66% (acute 30.17%, chronic
36.2%) for the control group; these costs seemed to dom-
inate the overall service costs. Costs varied from 38% to
93%, and were variable internationally [27]. Drug costs as
a percent overall healthcare cost in our study were much
higher than the drug costs in other counties. The average
drug costs in this study were 25% of total direct healthcare
costs, 14.6% in the study group, and 25.9% in the control
group, when compared with the cost in other countries,
which ranged from 2.3% to 13% [27]. In an extended
study of 10,972 cases across more than 10 countries in
Europe, most patients were prescribed atypical neurolep-
tics at their first medical consultation [22]. In all, a varia-
Table 3: Various associated costs for the two groups
Items (US$) Study group (N = 1210) Control group (N = 18911) tp
Clinic-total cost 485 636 -7.06 <0.001
Clinic-medication cost 244 403 -10.29 <0.001
Clinic-psychiatric treatment cost 26 28 -1.13 0.258
Home-based care – total cost 49 11 19.87 <0.001
Community rehabilitation – total costs 18 8 3.125 0.002
Acute hospital admission – total cost 3485 3253 1.74 0.081
Chronic hospital admission – total cost 3878 5353 -6.622 <0.001
Day admission center-total costs 2593 3436 -3.389 0.001
Psychiatric rehabilitation institution – total cost 317 1447 -11.24 <0.001
Total hospital admission costs 2319 1467 9.382 <0.001
Total hospital drug costs 166 149 1.424 0.155
Total hospital psychiatric treatment costs 503 169 21.76 <0.001
Average cost per patient 2737 2041 7.91 <0.001
Total medical cost 3,314,455 38,593,805
Currency conversion: US$: NT$ = 1: 32
Table 2: Frequency of visits for the two groups
Items Study group (N = 1210) Control group (N = 18911) tp
Frequency of clinic visits (no. of patients involved) 12.4 (1047) 12.2 (13417) 0.795 0.426
Frequency of home-based care (no. of patients involved) 2.9 (1210) 0.4 (14875) 36.22 <0.001
Community rehabilitation (days) 0.06 1.35 -2.97 0.017
Frequency of community rehabilitation (no. of patients involved) 0.18 (1210) 0.05 (14875) 6.14 <0.001
Acute hospital admission (in days) 77 64 4.865 <0.001
Frequency of acute hospital admissions (no. of patients involved) 2.83 (587) 1.4 (3005) 27.15 <0.001
Chronic hospital admission (in days) 159.6 209.5 -5.39 <0.001
Frequency of chronic hospital admissions (no. of patients involved) 1.52 (212) 1.32 (2366) 5.08 <0.001
Day admission center (in days) 141.7 157.4 -1.306 0.192
Frequency of day admission center usage (no. of patients involved) 2.10 (117) 1.21 (565) 12.02 <0.001
Frequency of psychiatric rehabilitation institution visits (no. of 
patients involved)
4.92 (72) 7.88 (234) -5.34 <0.001BMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
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tion was found between the two groups in our study, and
an evident variation was also found in European coun-
tries. Drug costs are expected to be proportionately higher
in developing countries, compared with developed coun-
tries [28]. Further evaluations are needed regarding the
cause of the lower drug costs in the study group, the
higher percentage of drug costs in Taiwan, and the per-
centage of prescriptions of atypical neuroleptics.
Many studies have discussed the reasons associated with
the costs of schizophrenia. Compatible with previous
findings, we found that the average length of stay (77
days) in the study group was longer than in the control
group (64 days), and the average age of patients in the
study group was 39.2 years, younger than the control
group at 42.8 years old. The readmission rate in the acute
ward of the study group (2.83 in 1 year) was much higher
than in the control group (1.4 in 1 year), which might be
why the direct costs of the study group were higher than
those of the control group. The high readmission rate
might suggest severe mental symptoms, lower GAF scores,
higher BPRS scores, and lower income [29]. According to
the findings of this study (Tables 1 and 2), the higher costs
of the study group might be due to the clinical differences
of the cases.
The report by Knapp suggested that some costs were very
difficult to determine. Although overall direct and indirect
costs in the Knapp report added up to 2.6 billion euros,
some indirect impacts were not measured, thus making
the estimation of indirect costs a difficult task. According
to the report published by the Department of Health, UK
[30], the costs for schizophrenia treatment were 5.4% of
the total medical budget, and 3% of the total expenditure
by the National Health Service [31]. Generally, the direct
costs of schizophrenia could be expected to be from 1.5%
to 3% of the total national healthcare expenditure [32-
34]. In our study, the higher resource utilization of schiz-
ophrenic patients was 4.12% of the total healthcare
resources of the Kao-Ping area, which might be due to Tai-
wan's social reform in recent years, in which the policy-
makers encouraged the development of mental health
services that would elevate hospital ranking.
With respect to medical outcomes, we found that the fol-
lowing factors are often associated with a lower quality of
life: sex (female), multiple episodes of schizophrenic psy-
Table 5: Comparison between the 1st and 2nd tests for the control group (N = 133)
1st test Mean ± SD 2nd test Mean ± SD Comparison Correlation
tp   Value rp   Value
Patient quality of life questionnaire
Physiological health 21.44 ± 5.09 19.67 ± 5.64 2.75 0.01** 0.04 0.67
Psychological health 16.99 ± 4.52 16.05 ± 4.89 1.76 0.08 0.13 0.15
Social relations 8.02 ± 2.66 7.39 ± 2.66 2.04 0.04* 0.14 0.11
Environment 23.67 ± 5.78 22.23 ± 6.65 1.93 0.06 0.04 0.61
Main caregiver
Burden load 26.77 ± 9.03 26.57 ± 11.78 0.15 0.88 -0.13 0.13
CHQ 13.87 ± 2.40 17.01 ± 5.43 -5.72 0.00** -0.15 0.09
Table 4: Comparison between the 1st and 2nd tests for the study group (N = 190)
1st test Mean ± SD 2nd test Mean ± SD Comparison Correlation
tp   value rp   value
Patient quality of life 
questionnaire
Physiological health 20.90 ± 4.98 21.08 ± 4.51 -0.39 0.69 0.53 0.47
Psychological health 16.69 ± 4.23 17.27 ± 3.88 -1.47 0.14 0.10 0.16
Social relations 7.42 ± 2.67 7.58 ± 2.77 -0.58 0.56 0.06 0.43
Environment 23.06 ± 5.46 23.89 ± 5.07 -1.58 0.12 0.07 0.37
Main caregiver
Burden load 28.11 ± 9.13 24.14 ± 8.77 4.39 0.00** 0.03 0.65
CHQ 14.44 ± 2.57 18.39 ± 5.02 -9.82 0.00** 0.03 0.64BMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
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chosis, longer duration of the disease, and severe psy-
chotic symptoms, such as with patients with higher BPRS
scores [35]. One study reported no differences in sub-
groups in terms of service utilization, quality of life, and
the caregiver's emotional satisfaction between male and
female patients [36]. Many patients in Italy lived at home,
with a hospital admission rate of 5.5%. They had a better
quality of life when compared with patients in USA (with
a hospital admission rate of 21%), because living at home
meant greater residential stability, more ownership, and
more people contacts [37]. In this study, the poorer qual-
ity of life in the control group might be due to longer
duration of hospital admissions and less home visiting.
According to this study, the mental health provider
should set up alternative services for the individual needs
of patients and families of different genders, ages, and
family incomes.
With regard to the families, our previous study revealed
that an older age, a shorter duration of the disease, and
severe psychotic symptoms were the predictors of a heav-
ier burden on families [35]. In this study, the factors that
influenced the caregivers' burden were the longer dura-
tion of the disease and the low income of the caregivers.
Further evaluation is needed regarding whether a different
case sample, factor of poverty, demographic distribution,
or interventions such as a study group, which have a
higher service contact rate, would lower the family bur-
den. In another study, psychological health and the bur-
den on families were significantly associated with a
shorter duration of the disease, showing that care giving
created a burden on the family [38]. In a study by the Con-
necticut Health Care System of the USA, patients with
severe psychotic symptoms, living in the community, and
with frequent family contact were correlated to a heavier
family burden [39]. Regardless of the type of service the
patient received, the acute onset, severe symptoms, and
frequent contact with the family were usually associated
with a greater burden and mental stress. In the network of
services in the study group, the continued follow-up of
each patient may have been a better approach to decrease
the family burden.
Inconsistencies were observed in family burden and CHQ
scores, which may be due to the fact that family burden
was more related to providing care for the patient, while
the psychological health of the family was more related to
secular changes. The CHQ scores were influenced by the
age of the caregivers: the older they were, the lower the
CHQ score (p = 0.045, table not shown). Regardless of the
type of care system, the caregivers were constantly under
enormous psychological stress. As time passed, the CHQ
scores of the caregivers increased, especially among the
younger caregivers, which should be taken into consider-
Table 6: Comparison between the study group and the control group
Study group (N1/N2 = 257/190) Control group (N1/N2 = 241/133) tp
Patient quality of life questionnaire
Physiological health:
1st test 23.10 20.23 -2.23 0.02
2nd test 21.09 19.67 -2.52 0.01
Psychological health:
1st test 17.02 16.36 -1.68 0.11
2nd test 17.27 16.05 -2.51 0.01
Social relations:
1st test 7.36 7.76 1.64 0.88
2nd test 7.58 7.39 -0.61 0.54
Environment:
1st test 23.37 22.93 -0.86 0.39
2nd test 23.89 22.23 -2.55 0.01
Total score:
1st test 81.32 78.93 -1.47 0.14
2nd test 81.75 76.56 -2.55 0.01
Main caregiver
Burden load:
1st test 27.25 27.76 0.62 0.53
2nd test 24.14 26.57 2.12 0.035
CHQ:
1st test 14.30 14.36 0.27 0.79
2nd test 18.39 17.01 -2.35 0.019BMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
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ation when using the CHQ as an outcome variable. The
outcome variance due to multiple informants, such as
that of the CHQ of the caregivers, cannot be ignored. Even
self-rated satisfaction reports completed by parents are
better predictors of the patient's satisfaction, and are more
sensitive than changes in the patient's psychotic symp-
toms [40,41]. This indicates that the psychological status
of the caregiver and the family should be further investi-
gated when promoting the healthcare management of
schizophrenia.
Conclusion
Indeed, the cost comparison analysis would be more con-
vincing if it was beyond the small number of participants
(257 study patients vs. 247 control patients), however, we
could only get the costs of two larger populations from the
government. This might be a limitation for generalization
in this study. In conclusion, we found that the costs of the
study group were higher than those of the control group,
but the QOL of the study group was higher and the family
burden lower than that of the control group. Moreover,
most patients of the study group were frequently admitted
to a hospital but with decreased length of hospital stay. At
a time of scarce medical resources with many countries
paying close attention to disease management, the pro-
motion of the community-based treatment model should
include the consideration of individual factors such as the
patient's sex, age, duration of the disease, social function-
ing, and the family support system. Treatment models
should be tailored to individual needs [42]. The findings
from studies of these models is an informative reference
for future designations of community mental health serv-
ice programs in Taiwan.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
Study concept and design: FWL.
Acquisition of data: DST, LCL, CUC, CYY, GTL, PP.
Analysis and interpretation of data: DST, LCL, CUC, CYY,
GTL, PP, FWL.
Drafting of the manuscript: DST, FWL.
Critical revision of the manuscript for important intellec-
tual content: DST, FWL.
Statistical analysis: DST, FWL.
Obtained funding: DST, FWL.
Administrative, technical, or material support: FWL.
Study supervision: FWL; FWL had full access to all the data
in the study and takes responsibility for the integrity of the
data and the accuracy of the data analysis.
All authors read and approved the final manuscript.
Acknowledgements
This study was supported by a grant (numbers 9309) from the Medical 
Affairs Bureau, Ministry of National Defense, Taiwan. Also, the authors 
would like to acknowledge all researchers who assisted in this study.
References
1. Lamb HR, Geertzel V: Discharged mental patients: are they
really in the community?  Arch Gen Psychiatry 1971, 24:29-34.
2. Turner JS, TenHoor WJ: The NIMH community support pro-
gram: pilot approach to needed social reform.  Schizophr Bull
1978, 4:319-344.
3. Marks IM, Connolly J, Muijen M, Audini B, McNamee G, Lawrence RE:
Home-based versus hospital-based care for people with seri-
ous mental illness.  Br J Psychiatry 1994, 165(2):179-194.
4. Scott JE, Dixon LB: Assertive community treatment and case
management for schizophrenia.  Schizophr Bull 1995,
21:657-668.
5. Knapp M, Beecham J, Fenyo A, Hallam A: Community mental
health care for former hospital in-patients; predicting costs
from needs and diagnoses.  Br J Psychiatry 1995:10-18.
6. Merson S, Tyrer P, Carlen D, Johnson T: The cost of treatment of
psychiatric emergencies: a comparison of hospital and com-
munity services.  Psychol Med 1996, 26(4):727-734.
7. Creed F, Mbaya P, Lancashire S, Tomenson B, Williams B, Holme S:
Cost effectiveness of day and in-patient psychiatric treat-
ment: results of a randomised controlled trial.  Br Med J 1997,
314(7091):1381-1385.
8. Tyrer P, Evans K, Gandhi N, Lamont A, Harrison-Read P, Johnson T:
Randomised controlled trial of two models of care for dis-
charged psychiatric patients.  Br Med J 1998,
316(7125):106-109.
9. Lehman AF: Public health policy, community services, and
outcomes for patients with schizophrenia.  Psychiatr Clin North
Am 1998, 21(1):221-223.
10. Phillips SD, Burns BJ, Edgar ER, Mueser KT, Linkins KW, Rosenheck
RA, Drake RE, McDonel Herr EC: Moving assertive community
treatment into standard practice.  Psychiatr Serv 2001,
52(6):771-779.
11. Lang HC, Su TP: The cost of schizophrenia treatment in Tai-
wan.  Psychiatr Serv 2004, 55(8):928-931.
12. WHOQOL Group: Measuring Quality of Life: The Development of the
World Health Organization Quality of Life Instrument (WHOQOL)
Geneva: WHO; 1993. 
13. WHOQOL Group: The development of the WHO quality of
life assessment instrument (the WHOQOL).  In Quality of Life
Assessment: International Perspective Edited by: Orley J, Kuyken W. Ber-
lin: Springer-Verlag; 1994:41-60. 
14. WHOQOL Group: Development of the WHOQOL: Rationale
and current status.  Int J Men Health 1994, 23:24-56.
15. Yao KP: The development and application of the WHOQOL-
Taiwan version.  Formos J Med 2002, 6(3):193-200.
16. Biegel DE, Milligan SE, Putnam PL, Song LY: Predictors of burden
among lower socioeconomic status caregivers of persons
with chronic mental illness.  Community Ment Health J 1994,
30(5):473-494.
17. Song LY: Development and testing of burden scoring table for
caregivers of patients with psychiatric illnesses.  Society Policies
Oper 2002, 6(1):61-92.
18. Cheng TA, Williams P: The design and development of a
screening questionnaire (CHQ) for use in community stud-
ies of mental disorders in Taiwan.  Psychol Med 1986,
16:415-422.
19. Chong MY, Wilkinson G: Validation of 30- and 12- item versions
of the Chinese Health Questionnaire (CHQ) in patientsPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Health Services Research 2007, 7:129 http://www.biomedcentral.com/1472-6963/7/129
Page 9 of 9
(page number not for citation purposes)
admitted for general health screening.  Psychol Med 1989,
19:495-505.
20. Cheng TA, Wu JT, Chong MY, Williams P: Internal consistency
and factor structure of the Chinese Health Questionnaire.
Acta Psychiatr Scand 1999, 82:304-308.
21. SPSS Inc: Statistical Package for Social Science: Release 10.0.7 Chicago,
IL: SPSS Inc; 2000. 
22. Haro JM, Edgell ET, Frewer P, Alonso J, Jones PB, SOHO Study
Group: The European Schizophrenia Outpatient Health Out-
comes Study: baseline findings across country and treat-
ment.  Acta Psychiatr Scand 2003:7-15.
23. Salize HJ, Rossler W: The cost of comprehensive care of people
with schizophrenia living in the community. A cost evalua-
tion from a German catchment area.  Br J Psychiatry 1996,
169:42-48.
24. Beecham JK, Fenyo AJ, Hallam A: Community mental health care
for former hospital in-patients: predicting costs from needs
and diagnoses.  Br J Psychiatry 1995:10-18.
25. Moscarelli MS, Capri S, Neri L: Cost evaluation of chronic schiz-
ophrenic patients during the first three years after first con-
tact.  Schizophr Bull 1991, 17(3):421-426.
26. Rossi A, Amaddeo F, Bisoffi G, Ruggeri M, Thornicroft G, Tansella M:
Dropping out of care: inappropriate terminations of contact
with community-based psychiatric services.  Br J Psychiatry
2002, 181:331-338.
27. Knapp M, Novick D, Genkeer L, Curran CM, McDaid D, SOHO Study
Group:  Financing health care in Europe: context for the
Schizophrenia Outpatient Health Outcomes Study.  Acta Psy-
chiatr Scand 2003:30-40.
28. Suleiman TG, Ohaeri JU, Lawal RA, Haruna AY, Orija OB: Financial
cost of treating out-patients with schizophrenia in Nigeria.
Br J Psychiatry 1997, 171:364-368.
29. Knapp M, Chisholm D, Leese M, Amaddeo F, Tansella M, Schene A,
Thornicroft G, Vazquez-Barquero JL, Knudsen HC, Becker T, EPSI-
LON study group: Comparing patterns and costs of schizo-
phrenia care in five European countries: the EPSILON study.
Acta Psychiatr Scand 2002, 105(1):42-54.
30. Knapp M, Almond S, Percudani M: Costs of schizophrenia: A
Review.  In Schizophrenia (WPA series in Evidence and Experience in Psy-
chiatry) Volume 2. Edited by: Maj M, Sartorius N. West Sussex, UK:
John Wiley & Sons Ltd; 1999. 
31. Knapp M: Cost of schizophrenia.  Br J Psychiatry 1997,
171:509-518.
32. Evers SM, Ament AJ: Cost of schizophrenia in the Netherlands.
Schizophr Bull 1995, 21(1):141-153.
33. Rice DP, Miller LS: Health economics and cost implications of
anxiety and other mental disorders in the United States.  Br
J Psychiatry 1998:4-9.
34. De Hert M, Thys E, Peuskens J: The cost of schizophrenia.  Acta
Psychiatr Belg 1998:9-16.
35. Tzeng DS, Lung FW, Chang YY: Comparison of the quality of life
of people with schizophrenia and the mental health of car-
egivers between community-based and hospital-based serv-
ices.  Kaohsiung J Med Science 2004, 20(9):443-451.
36. Thornicroft G, Leese M, Tansella M, Howard L, Toulmin H, Herran
A, Schene A: Gender differences in living with schizophrenia.
A cross-sectional European multi-site study.  Schizophr Res
2002, 157(2–3):191-200.
37. Warner R, de Girolamo G, Belelli G, Bologna C, Fioritti A, Rosini G:
The quality of life of people with schizophrenia in Boulder,
Colorado, and Bologna, Italy.  Schizophr Bull 1998,
24(4):559-568.
38. Martens L, Addington J: The psychological well-being of family
members of individuals with schizophrenia.  Soc Psychiatry Psy-
chiatr Epidemiol 2001, 36(3):128-133.
39. Rosenheck R, Cramer J, Jurgis G, Perlick D, Xu W, Thomas J, Hend-
erson W, Charney D: Clinical and psychopharmacologic fac-
tors influencing family burden in refractory schizophrenia.  J
Clin Psychiatry 2000, 61(9):671-676.
40. Lambert W, Salzer MS, Bickman L: Clinical outcome, consumer
satisfaction, and ad hoc ratings of improvement in children's
mental health.   J Consult Clin Psychol 1998, 66(2):270-279.
41. Faulkner A, Thomas P: User-led research and evidence-based
medicine.  Br J Psychiatry 2002, 180:1-3.
42. Dickey B, Normand SL, Hermann RC, Eisen SV, Cortes DE, Cleary
PD, Ware N: Guideline recommendations for treatment of
schizophrenia: the impact of managed care.  Arch Gen Psychiatry
2003, 60(4):340-348.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6963/7/129/pre
pub